Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Hutchens & Kramer Investment Management Group LLC

Hutchens & Kramer Investment Management Group LLC decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 520 shares of the medical equipment provider’s stock after selling 26 shares during the quarter. Hutchens & Kramer Investment Management Group LLC’s holdings in Intuitive Surgical were worth $271,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of ISRG. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $26,000. Godsey & Gibb Inc. increased its stake in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the third quarter worth $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in shares of Intuitive Surgical in the third quarter worth $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $573.48 on Tuesday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The stock has a market cap of $204.26 billion, a PE ratio of 92.20, a P/E/G ratio of 5.19 and a beta of 1.39. The firm has a 50-day simple moving average of $547.16 and a two-hundred day simple moving average of $505.21.

Insider Buying and Selling at Intuitive Surgical

In related news, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the transaction, the insider now owns 8,757 shares in the company, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 42,265 shares of company stock worth $21,964,281 over the last three months. Insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Evercore ISI increased their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday. Piper Sandler reiterated an “overweight” rating and issued a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday. Mizuho raised their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Wells Fargo & Company raised their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.